A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight

Conditions: Obesity Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Atorvastatin; Drug: Warfarin Sponsors: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials